After completing this activity, pharmacists should be able to:
- list factors contributing to poor seizure control in pregnancy;
- recognise the common congenital anomalies in foetal valproate syndrome;
- discuss alternatives to sodium valproate for bipolar affective disorder and migraine prevention;
- identify risk profile for congenital anomalies for antiepileptic medicines in pregnancy.
The 2016 Competency Standards addressed by this activity include: 1.4, 1.5, 3.1, 3.2, 3.3, 3.6
Accreditation number: A2002AJP1 Accreditation expires: 01/02/2022
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.